IPOPI

Improving PID patients’ lives. Worldwide. 

  • Home
  • About IPOPI
    • Mission and objectives
    • Executive Committee
    • Medical Advisory Panel
    • Staff
    • Member organisations
    • Network of Experts
    • History
    • IPOPI Governance
    • Corporate partners
    • Finances and transparency
  • Our Work
    • IPOPI strategic plan
      • Early diagnosis and care
      • NMO support
      • PID awareness
      • Stakeholder collaboration
    • Donate to IPOPI
  • PIDs
    • What are Primary Immunodeficiencies?
    • PIDs FAQs
  • NMOs
    • IPOPI NMO Toolkit
    • NMO Documents
  • •
  • Menu
  • Publications
    • Leaflets
    • Reviews
    • Key publications
    • News
  • PID Life Index
  • Media
  • e-News
  • IPOPI TV
  • Apps
    • 4ID Health Agenda
    • Q-ID Quiz App

New position statement: IPOPI welcomes newly elected European Parliament

Key publications, News
Read more
19th June 2024/by IPOPI
https://ipopi.org/wp-content/uploads/2024/06/IMG-20240321-WA0099.jpg 1060 1151 IPOPI https://ipopi.org/wp-content/uploads/2017/06/LOGO.svg IPOPI2024-06-19 16:22:112025-02-07 14:36:35New position statement: IPOPI welcomes newly elected European Parliament

New Article: Newborn Screening Today and Tomorrow

News
Read more
9th April 2024/by IPOPI
https://ipopi.org/wp-content/uploads/2024/04/Untitled-design-7.png 262 407 IPOPI https://ipopi.org/wp-content/uploads/2017/06/LOGO.svg IPOPI2024-04-09 13:39:142025-02-07 14:37:54New Article: Newborn Screening Today and Tomorrow

IPOPI joins the Critical Medicines Alliance

News
Read more
2nd April 2024/by IPOPI
https://ipopi.org/wp-content/uploads/2024/04/cma-banner.jpg 303 741 IPOPI https://ipopi.org/wp-content/uploads/2017/06/LOGO.svg IPOPI2024-04-02 11:10:282025-01-08 14:31:04IPOPI joins the Critical Medicines Alliance

Three Newly Published IPOPI Information Leaflets

News
Read more
18th March 2024/by IPOPI
https://ipopi.org/wp-content/uploads/2024/03/2.png 720 1200 IPOPI https://ipopi.org/wp-content/uploads/2017/06/LOGO.svg IPOPI2024-03-18 16:23:372025-01-08 14:26:20Three Newly Published IPOPI Information Leaflets

New statement: Patients with PIDs should have access to safe, efficacious and high-quality immunoglobulin therapies

Key publications, News
Read more
12th March 2024/by IPOPI
https://ipopi.org/wp-content/uploads/2024/03/IG-vials-1-scaled.jpg 1700 2560 IPOPI https://ipopi.org/wp-content/uploads/2017/06/LOGO.svg IPOPI2024-03-12 09:54:502025-01-08 14:30:11New statement: Patients with PIDs should have access to safe, efficacious and high-quality immunoglobulin therapies
Page 4 of 7«‹23456›»
  • Home
  • About IPOPI
    • Mission and objectives
    • Executive Committee
    • Medical Advisory Panel
    • Staff
    • Member organisations
    • Network of Experts
    • History
    • IPOPI Governance
    • Corporate partners
    • Finances and transparency
  • Our Work
    • IPOPI strategic plan
      • Early diagnosis and care
      • NMO support
      • PID awareness
      • Stakeholder collaboration
    • Donate to IPOPI
  • PIDs
    • What are Primary Immunodeficiencies?
    • PIDs FAQs
  • NMOs
    • IPOPI NMO Toolkit
    • NMO Documents
  • Publications
    • Leaflets
    • Reviews
    • Key publications
    • News
  • PID Life Index
  • Media
  • e-News
  • IPOPI TV
  • Apps
    • 4ID Health Agenda
    • Q-ID Quiz App

Privacy Policy and Cookies

Privacy Policy
Cookies Policy
Change cookie settings

Contact us

Belgium
Avenue Louise/Louizalaan 65, Bte 11
BE-1050 Brussels, Belgium
IPOPI aisbl is an international non-profit association registered in Belgium
Numéro d’entreprise
BE 0761.784.055

Email: info@ipopi.org

Tel: +32 2 790 73 66 (Belgium)

Social Media

Contact us

Calendar

Donate

Website sponsors

Copyright © 2023 IPOPI. All Rights Reserved.
Scroll to top